Medications


Moderna COVID-19 Vaccine Candidate

On November 30, 2020, Moderna, Inc., a biotechnology company that specializes in RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines…








FDA Approves First Treatment for Ebola

On October 14, through immediate press-release FDA (Food and Druf Administration of U.S.) approved Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn), a mixture of three monoclonal antibodies,…